mediguide4u logo
mediguide4u
NavigationHomeAbout UsHealth GuidesHealth ToolsQuizzesMedical BoardFAQContact
Account
LoginRegister
Digestive Health & Clinical NutritionNeurogastroenterology & Microbiome

Irritable Bowel Syndrome (IBS): Subtypes, Visceral Hypersensitivity, and Low-FODMAP Diet

Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder (FGBI) that affects around 10% of the world population and causes recurring abdominal discomfort with changes to bowel habits. The Rome IV criteria will be reviewed, along with specific sub-types of IBS (IBS-C, IBS-D, IBS-M). Visceral hypersensitivity will be discussed alongside Small Intestinal Bacterial Overgrowth (SIBO), and finally the 3 phase low-FODMAP elimination and challenge protocol.

R
Written by Dr. Randhir Sud, MBBS, MD, DM, MAMSChairman, Institute of Digestive & Hepatobiliary Sciences, Medanta – The Medicity
Medically Reviewed by Dr. Shikha Sharma, MBBS✓ Verified
MBBS (Maulana Azad Medical College)• Reviewed October 2026•Medical Review Board
Published: 2026-09-12Reviewed: October 2026Updated: 2026-11-02T13:14:22.416Z 10 min read 2122 Views
Listen to this guide Audio Edition

Hands-free audio narration

Educational Health Notice

This educational guide is researched in accordance with our Editorial Policy and public health guidelines. It is not personal medical advice. For clinical questions, read our Medical Disclaimer or consult a qualified healthcare provider.

Irritable Bowel Syndrome (IBS): Subtypes, Visceral Hypersensitivity, and Low-FODMAP Diet

Quick Summary & Key Findings

Irritable Bowel Syndrome (IBS) is diagnosed using the Rome IV criteria based on recurrent abdominal pain on average one or more days per week in the last three months related to defecation and associated with a change in stool frequency/consistency. The most clinically proven diet therapy for IBS patients is a 3 phase Low-FODMAP diet (Elimination, Reintroduction and Personalisation). This limits the intake of poorly absorbed short chain fermentable carbohydrates which are responsible for causing gas distension, osmotic diarrhoea and visceral pain in sensitive guts.

Many patients with chronic bloating, severe cramping and irregular bowel patterns have been told their symptoms are ‘all in their heads’ as they present with normal results from routine investigations such as colonoscopies and blood tests. Neurogastroenterology has now identified that Irritable Bowel Syndrome (IBS) is a well understood Disorder of Gut-Brain Interaction (DGBI).

IBS causes complex dysfunction in communication between the enteric nervous system (second brain in the gut) and central nervous system. This causes visceral hypersensitivity (pain threshold lowered) meaning that normal gas production and digestion within the intestine will be felt as stabbing painful discomfort.

With exact patient classification and following the evidence based 3 phase protocol developed by Monash University known as the Low-FODMAP diet, over 70% of IBS sufferers can overcome their debilitating digestive symptoms with the help of clinicians or dieticians.

The Rome IV Diagnostic Criteria and IBS Subtypes

IBS is diagnosed clinically based on symptom patterns after excluding organic disease (celiac disease, IBD):
Rome IV Diagnostic Criteria: Abdominal pain that occurs on average 1 day per week over the past three months. Must be associated with 2 or more of the following criteria: 1) Pain related to defecation (relieved or exacerbated by bowel movement) 2) Altered stool frequency 3) Altered stool form (Bristol Stool Scale)
IBS-C (Constipation-Predominant): >25% of bowel movements are hard/formed stools (Bristol 1-2), <25% are loose stools – Treated with Osmotic laxatives (polyethylene glycol) and Secretagogues (lubiprostone/linaclotide).
IBS-D (Diarrhea-Predominant): >25% of bowel movements are unformed/liquid (Bristol 6-7). Treated with peripheral opioid agonists (loperamide, eluxadoline) or non-absorbable antibiotics (rifaximin).
IBS-M (Mixed Bowel Habits): Alternating bouts of both constipation and diarrhea.
Red flag symptoms (not IBS) requiring alarm: Unintentional weight loss, rectal bleeding, nocturnal diarrhoea waking, family history of colorectal cancer or IBD, over the age of 50, high fecal calprotectin. (Colonoscopy required for diagnosis)

The 3-Phase Low-FODMAP Protocol (Monash University)

FODMAPs (Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols) are short chain carbohydrates which have an osmotic effect in the small intestine, drawing water into the gut. These carbohydrates undergo rapid fermentation by bacteria in the colon producing hydrogen and methane gases:
Strict Elimination (2-6 weeks) Phase 1 Remove all high FODMAP foods. This includes Fructans (F), such as high fructose corn syrup, apples, honey; Lactose (L) found in cow’s milk and soft cheeses; Fructans (F) found in wheat, onions, garlic; Galacto-oligosaccharides (G), such as beans and lentils; plus Polyols (P) including sorbitol, mannitol, stone fruits and sugar alcohols.
Phase 2: Systematic Challenge Phase (6-8 weeks) During this phase you will challenge yourself to eat one type of FODMAP food at a time for 3 days (e.g. fructose with honey, fructans with garlic). This phase will help you identify your individual trigger foods and how much food you can tolerate.
Phase 3: Personalization (long term) Reintroduce all tolerated foods. Only avoid high trigger foods. NEVER permanently follow a strict Low FODMAP diet as this will starve the good bifidobacteria in your gut.

Gut-Brain Neuromodulators and Psychological Therapies

Targeting the enteric nervous system provides symptom relief when dietary adjustments alone are insufficient:
Gut-Directed Hypnotherapy – A validated randomised trial which can reduce symptoms to a similar extent as the Low-FODMAP diet by re-training central sensory processing of gut signals.
Low-Dose Neuromodulators (Tricyclics like Amitriptyline 10–25 mg): Acts as central and visceral analgesics, reducing intestinal hypersensitivity and slowing transit in IBS-D.
Peppermint Oil (Enteric-Coated): Natural L-menthol blocks calcium channels in intestinal smooth muscle, providing rapid antispasmodic relief for postprandial cramping.

Microbiome Modulators: Prebiotics, Probiotics, Synbiotics, & Postbiotics

Modulator ClassDefinition & MechanismKey Food Sources / ExamplesClinical Health Benefits
Prebiotics (Microbial Fuel)Non-digestible soluble dietary fibers that selectively fuel beneficial commensal gut bacteria.Inulin (chicory root, garlic, onions, leeks), Resistant Starch (cooled potatoes/rice), Oats, Legumes.Maximizes endogenous Butyrate/SCFA production; lowers colonic pH to inhibit pathogens.
Probiotics (Live Microbes)Live microorganisms that, when administered in adequate amounts, confer a health benefit.Lactobacillus rhamnosus GG, Bifidobacterium longum, Saccharomyces boulardii (beneficial yeast).Restores microbial equilibrium after antibiotics; shortens infectious diarrhea; alleviates IBS symptoms.
Fermented Foods (Live Cultures)Whole foods fermented by live bacterial and fungal cultures producing diverse metabolites.Kefir, unpasteurized sauerkraut, authentic kimchi, live-culture Greek yogurt, miso, tempeh.Increases overall microbiome alpha-diversity and reduces circulating inflammatory markers (IL-6).
Postbiotics (Bioactive Byproducts)Inanimate microorganisms and/or their cellular components and metabolic byproducts.Sodium Butyrate, bacterial cell wall fragments, bacteriocins, heat-killed probiotics.Directly enhances mucosal barrier integrity and modulates immune receptors without live bacteria risks.

The '30 Plant Species Weekly' Dietary Diversity Protocol

The landmark American Gut Project proven rule for maximum microbial diversity:
Aim to eat 30+ different plants per week. Count each individual vegetable, fruit, legume, wholegrain, nut, seed, herb and spice you consume. People who consume 30+ different plant foods are much more likely to have a diverse microbiome than those who consume less than 10.
Incorporate Fermented Foods Daily: Consume 1 to 2 servings of fermented foods (such as 4 oz of kefir, 2 tablespoons of kimchi, or live-culture yogurt) daily.
Use Resistant Starch. Cook your starchy food (potatoes, sweet potatoes, rice) and refrigerate overnight. This will convert the digested starches into retrograde resistant starch which will go straight to the large intestine to be used by butyrate producing bacteria.
Avoid ultra-processed emulsifiers such as polysorbate-80 and carboxymethylcellulose found in processed foods as they remove the protective barrier of mucus lining your colon and create micro inflammation.

When to Consult a Gastroenterologist

Schedule a comprehensive evaluation if you experience:
  • Persistent severe bloating, chronic diarrhea, or alternating bowel habits (Screening for SIBO, Celiac, or IBD)
  • Unexplained blood in your stool, dark tarry stools, or chronic iron deficiency anemia
  • Post-antibiotic watery diarrhea accompanied by fever and abdominal cramping (Mandatory *Clostridioides difficile* testing)
  • Unintentional rapid weight loss accompanied by chronic gastrointestinal distress

Visceral Hypersensitivity, The Rome IV Criteria & Gut-Brain Axis Signaling

Irritable Bowel Syndrome (IBS) is a classic example of a gut-brain interaction disorder (DGBI). It involves chronic recurring pains in the abdomen associated with changes in bowel habit without any evidence of structural or biochemical change. Pathophysiology includes visceral hypersensitivity (low pain threshold to normal rectal distension), changes to motility, mild immune activation in the mucosa. There is also increased epithelial permeability of the intestine (leaky gut). The microbiome-gut-brain axis is bidirectional through autonomic nerves, the HPA axis and bacterial neuroactive products (short chained fatty acids). This affects pain amplification in the central nervous system at the anterior cingulate cortex and insula.
Rome IV Diagnostic Criteria: Recurrent abdominal pain at least 1 day/week on average over the past 3 months; pain must have begun at least 6 months ago. Pain is associated with two or more of the following: (1) Related to defecation (2) Changes in bowel frequency (3) Changes in stool form/appearance.
Bristol Stool Form Scale Subtyping: Patients can be divided into 4 clinical subtypes. These are; IBS with Constipation (IBS-C) (>25% hard/lumpy stools, <25% loose), IBS with Diarrhea (IBS-D) (>25% loose/watery stools, <25% hard), IBS Mixed (IBS-M) (>25% hard AND >25% loose), and IBS Unclassified.
Red-flag indications requiring alarm investigation: Exclude organic pathology by history taking and investigations. Age over 50 years, unexplained weight loss, nocturnal diarrhoea disturbing sleep, gross rectal bleeding, family history of colorectal cancer or inflammatory bowel disease (IBD), fever.
Fecal Calprotectin and Celiac Serology: Guidelines recommend testing fecal calprotectin (negative predictive value of 95%, active inflammatory bowel disease excluded if less than 50ug/g) as well as tissue transglutaminase IgA (tTG-IgA and total serum IgA) to exclude celiac sprue before diagnosing IBS-D.

The Monash 3-Phase Low-FODMAP Protocol & Central Neuromodulators

Therapeutic management includes dietary exclusion of fermentable carbohydrates, gut peripheral antispasmodics and central neuromodulators.
Monash University 3-Phase Low-FODMAP Framework: 1. Phase 1: Elimination phase (eliminate high FODMAP foods (Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols) for 2-6 weeks); 2. Phase 2: Re-challenge phase (challenge with single FODMAP foods over 3 days to determine individual trigger category); 3. Phase 3: Integration phase (re-introduce foods that are tolerated to ensure long term diversity of prebiotic colonic microbiota).
Why FODMAPs cause symptoms: The small molecule nature of FODMAPS causes an osmotic effect in the distal small bowel/colon causing an influx of water into the lumen. This is accompanied by a rapid fermentation by the anaerobic bacteria in the colon creating a mixture of gases (methane, hydrogen and carbon dioxide). This causes distension of hyper-sensitive visceral mechanoreceptors.
Central Neuromodulators (Gut-Brain Pharmacotherapy): Low dose Tricyclic Antidepressants (Amitriptyline 10-25mg nocte) can be used to slow gut transit and relieve neuropathic visceral pain in IBS-D. Selective Serotonin Reuptake Inhibitors (SSRI's) speed up gut transit and relieve visceral anxiety in IBS-C.
Enteric-Coated Peppermint Oil & Antispasmodics L-menthol (enteric coated peppermint oil) causes inhibition of voltage gated calcium channels in the smooth muscle of the intestines, therefore producing a quick acting antispasmodic effect without causing Upper Esophageal Reflux.

Frequently Asked Questions

S
Clinical Reviewer License Verified

Dr. Shikha Sharma, MBBS

Founder & Medical Director, NutriHealth Delhi NCR; Clinical Nutrition Lead • MBBS (Maulana Azad Medical College)
Medical Review Board

Dr. Shikha Sharma is an MBBS graduate from Maulana Azad Medical College (MAMC), New Delhi, and a pioneer in clinical nutrition, gut health, and preventive lifestyle medicine in Delhi NCR with over 25 years of medical consulting experience.

License ID: DMC-12490
Medical Director, NutriHealth Delhi NCR; Consulting Preventive Physician
Medically evaluated on October 2026View Dr. Profile, Verified Credentials & Articles

References & Clinical Resources

  1. Clinical Research Faculty & Editorial Team. ACG Clinical Guideline: Management of Irritable Bowel Syndrome (2020-2026). [Access Resource Link] — The American Journal of Gastroenterology
  2. Clinical Research Faculty & Editorial Team. Efficacy of the Low FODMAP Diet for Treating Irritable Bowel Syndrome: The Evidence to Date (2020-2026). [Access Resource Link] — Clinical and Experimental Gastroenterology
  3. Clinical Research Faculty & Editorial Team. Rome IV Diagnostic Criteria for Disorders of Gut-Brain Interaction (2020-2026). [Access Resource Link] — Gastroenterology
Article Tools & Sharing:
Educational Resources

Related Healthcare Guides

Patient Community Doctor Reviewed

Reader Reviews & Clinical Q&A

Real experiences, reader questions, and verified physician guidance.

5.0 out of 5 (2 reviews)
CW
Carl W., PatientVerified Patient
•August 18, 2026

The detailed stage breakdown and laboratory biomarker tables helped me understand my recent lab results and collaborate much more effectively with my specialist.

Dr. S.K. Sarin, MBBS, MD, DM (Gastro), FNAHepatologist & Director, ILBS
August 19, 2026

Empowered patients who understand their biomarkers achieve the best long-term clinical outcomes, Carl. Keep working closely with your healthcare team.

NB
Nurse Brenda K., Clinical CoordinatorHealthcare Professional
•August 29, 2026

Clear explanation of etiology, dietary interventions, and pharmacological management. The safety callouts regarding when to seek immediate medical attention are especially valuable.

Dr. S.K. Sarin, MBBS, MD, DM (Gastro), FNAHepatologist & Director, ILBS
August 30, 2026

Highlighting clinical red flags ensures patient safety while providing robust home management literacy, Brenda. Thank you for your feedback!

Leave a Review or Ask a Medical Question

5 / 5 Stars
* Reviews are reviewed by our clinical editorial team in accordance with our medical policies.